Display Single Record

FOI Request

Disclosure ID
FOI/02911
Request Date
January 14, 2019
Subject
Asthma
Description

1. In your trust, in the past 3 months [latest 3 months available], how many asthma patients aged 18 and over have been treated [with a drug]?

2. How many paediatric asthma treated patients [aged 6-17] have been treated in the last 3 months?

3. How many severe asthmatic patients [BTS guidelines, step 4 or 5] have been treated in the last 3 months?

  1. How many patients have been treated in the last 3 months with:

Omalizumab [Xolair]

Mepolizumab [Nucala]

Reslizumab [Cinqaero]

Benralizumab [Fasenra]

Other [Please state]

5. How many paediatric patients have treated in the last 3 months with Xolair/Omalizumab?

  1. Could you please provide me with the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs ;

Ocreotide

Lanreotide

Pasireotide

Pegvisomant

Response
  1. To determine if we hold this information and retrieve it would require a manual trawl of patient case notes which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).
  2. To determine if we hold this information and retrieve it would require a manual trawl of patient case notes which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).
  3. To determine if we hold this information and retrieve it would require a manual trawl of patient case notes which would exceed 18 hours. This information is therefore exempt on the grounds of cost (Section 12(1)).
  4. We can confirm our Trust has prescribed Omalizumab [Xolair] in the last 3 months.

     

    The information you have requested relates to a very small number of individuals and is classed as personal data. To provide further detail may breach their confidentiality and therefore we are exempting this information under Section 40(2) of the FOI Act.

  5. None
  6. We can confirm the following numbers of patients treated in the last 12 months [latest 12 months possible] with the following drugs are;

    Ocreotide 0

    Lanreotide 16

    Pasireotide0

    Pegvisomant 0

Attachment 1
Attachment 2
Attachment 3
Attachment 4
Attachment 5
Attachment 6